161 related articles for article (PubMed ID: 20412040)
1. Modeling the interactions between alpha(1)-adrenergic receptors and their antagonists.
Du L; Li M
Curr Comput Aided Drug Des; 2010 Sep; 6(3):165-78. PubMed ID: 20412040
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.
Leonardi A; Barlocco D; Montesano F; Cignarella G; Motta G; Testa R; Poggesi E; Seeber M; De Benedetti PG; Fanelli F
J Med Chem; 2004 Apr; 47(8):1900-18. PubMed ID: 15055991
[TBL] [Abstract][Full Text] [Related]
3. Ligand design for alpha(1) adrenoceptors.
Bremner JB; Griffith R; Coban B
Curr Med Chem; 2001 May; 8(6):607-20. PubMed ID: 11281844
[TBL] [Abstract][Full Text] [Related]
4. Pharmacophore development for antagonists at alpha 1 adrenergic receptor subtypes.
Bremner JB; Coban B; Griffith R
J Comput Aided Mol Des; 1996 Dec; 10(6):545-57. PubMed ID: 9007688
[TBL] [Abstract][Full Text] [Related]
5. Selective pharmacophore design for alpha1-adrenoceptor subtypes.
MacDougall IJ; Griffith R
J Mol Graph Model; 2006 Sep; 25(1):146-57. PubMed ID: 16406718
[TBL] [Abstract][Full Text] [Related]
6. Identification of critical extracellular loop residues involved in alpha 1-adrenergic receptor subtype-selective antagonist binding.
Zhao MM; Hwa J; Perez DM
Mol Pharmacol; 1996 Nov; 50(5):1118-26. PubMed ID: 8913343
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in alpha1-adrenoreceptor antagonists as pharmacological tools and therapeutic agents.
Rosini M; Bolognesi ML; Giardinà D; Minarini A; Tumiatti V; Melchiorre C
Curr Top Med Chem; 2007; 7(2):147-62. PubMed ID: 17266603
[TBL] [Abstract][Full Text] [Related]
8. Alpha 1-adrenoceptor subtype selectivity: molecular modelling and theoretical quantitative structure-affinity relationships.
De Benedetti PG; Fanelli F; Menziani MC; Cocchi M; Testa R; Leonardi A
Bioorg Med Chem; 1997 May; 5(5):809-16. PubMed ID: 9208092
[TBL] [Abstract][Full Text] [Related]
9. Identification of binding sites of prazosin, tamsulosin and KMD-3213 with alpha(1)-adrenergic receptor subtypes by molecular modeling.
Ishiguro M; Futabayashi Y; Ohnuki T; Ahmed M; Muramatsu I; Nagatomo T
Life Sci; 2002 Oct; 71(21):2531-41. PubMed ID: 12270758
[TBL] [Abstract][Full Text] [Related]
10. α₁-Adrenoceptor and serotonin 5-HT(1A) receptor affinity of homobivalent 4-aminoquinoline compounds: an investigation of the effect of linker length.
Chen J; Murad AK; Wakelin LP; Denny WA; Griffith R; Finch AM
Biochem Pharmacol; 2013 May; 85(10):1534-41. PubMed ID: 23524075
[TBL] [Abstract][Full Text] [Related]
11. Heterodimers of alpha1B- and alpha1D-adrenergic receptors form a single functional entity.
Hague C; Lee SE; Chen Z; Prinster SC; Hall RA; Minneman KP
Mol Pharmacol; 2006 Jan; 69(1):45-55. PubMed ID: 16195468
[TBL] [Abstract][Full Text] [Related]
12. Phenylpiperazinylalkylamino substituted pyridazinones as potent alpha(1) adrenoceptor antagonists.
Barlocco D; Cignarella G; Piaz VD; Giovannoni MP; De Benedetti PG; Fanelli F; Montesano F; Poggesi E; Leonardi A
J Med Chem; 2001 Jul; 44(15):2403-10. PubMed ID: 11448222
[TBL] [Abstract][Full Text] [Related]
13. Relationship between alpha(1)-adrenergic receptor-induced contraction and extracellular signal-regulated kinase activation in the bovine inferior alveolar artery.
Hague C; Gonzalez-Cabrera PJ; Jeffries WB; Abel PW
J Pharmacol Exp Ther; 2002 Oct; 303(1):403-11. PubMed ID: 12235277
[TBL] [Abstract][Full Text] [Related]
14. Phenylalanine in the second membrane-spanning domain of alpha 1A-adrenergic receptor determines subtype selectivity of dihydropyridine antagonists.
Hamaguchi N; True TA; Saussy DL; Jeffs PW
Biochemistry; 1996 Nov; 35(45):14312-7. PubMed ID: 8916917
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and structure-activity relationships of phthalimide-phenylpiperazines: a novel series of potent and selective alpha(1)(a)-adrenergic receptor antagonists.
Kuo GH; Prouty C; Murray WV; Pulito V; Jolliffe L; Cheung P; Varga S; Evangelisto M; Wang J
J Med Chem; 2000 Jun; 43(11):2183-95. PubMed ID: 10841797
[TBL] [Abstract][Full Text] [Related]
16. Identification of critical determinants of alpha 1-adrenergic receptor subtype selective agonist binding.
Hwa J; Graham RM; Perez DM
J Biol Chem; 1995 Sep; 270(39):23189-95. PubMed ID: 7559466
[TBL] [Abstract][Full Text] [Related]
17. Computational studies of the binding site of alpha1A-adrenoceptor antagonists.
Li M; Fang H; Du L; Xia L; Wang B
J Mol Model; 2008 Oct; 14(10):957-66. PubMed ID: 18626669
[TBL] [Abstract][Full Text] [Related]
18. KMD-3213, a novel, potent, alpha 1a-adrenoceptor-selective antagonist: characterization using recombinant human alpha 1-adrenoceptors and native tissues.
Shibata K; Foglar R; Horie K; Obika K; Sakamoto A; Ogawa S; Tsujimoto G
Mol Pharmacol; 1995 Aug; 48(2):250-8. PubMed ID: 7651358
[TBL] [Abstract][Full Text] [Related]
19. Arylpiperazines with affinity toward alpha(1)-adrenergic receptors.
Manetti F; Corelli F; Strappaghetti G; Botta M
Curr Med Chem; 2002 Jul; 9(13):1303-21. PubMed ID: 12052168
[TBL] [Abstract][Full Text] [Related]
20. Cloning of the human alpha 1d-adrenergic receptor and inducible expression of three human subtypes in SK-N-MC cells.
Esbenshade TA; Hirasawa A; Tsujimoto G; Tanaka T; Yano J; Minneman KP; Murphy TJ
Mol Pharmacol; 1995 May; 47(5):977-85. PubMed ID: 7746284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
